Loading provider…
Loading provider…
Gastroenterology Physician in Victoria, TX
NPI: 1225142623Primary Practice Location
MEMORIAL HERMANN REHABILITATION HOSPITAL KATY
21720 Kingsland Blvd, Katy, TX
Primary Employer
Victoria Gastroenterology
citizensmedicalcenter.org
HQ Phone
Get M.D. Dharmendra's Phone Numberphone_androidMobile
Get M.D. Dharmendra's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2006 - 2025

American Board of Internal Medicine
Gastroenterology
University of Texas Health Science Center at Houston
Fellowship • Gastroenterology
2006 - 2010
Residency • Internal Medicine
2003 - 2006
Delhi University College of Medical Sciences
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 532 | 952 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 237 | 272 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 208 | 216 |
| 4 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 198 | 199 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 161 | 161 |
Histopathologic correlation of endoscopic ultrasound findings of chronic pancreatitis in human autopsies.
Authors: Manoop Bhutani
Publication Date: 2009-10
Complete esophageal obstruction: an ususual complication of esophageal variceal ligation
Authors: D. Verma, C. Pham, A. Madan
Publication Date: 2009-01
Is endoscopic ultrasound "sound" for pancreatic cancer screening?
Authors: Sushovan Guha, Manoop Bhutani, Jason Fleming
Journal: J Clin Gastroenterol
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Bezafibrate 100 mg, DRUG: Bezafibrate 200 mg, DRUG: Obeticholic Acid 5 mg, DRUG: Obeticholic Acid placebo, DRUG: Bezafibrate Placebo
Lead Sponsor: Eli Lilly and Company
Collaborators: GlaxoSmithKline, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd., Vir Biotechnology, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Bebtelovimab, DRUG: Etesevimab, DRUG: Bamlanivimab, DRUG: VIR-7831
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab